Sari Pesonen

Sari Pesonen

Company: Valo Therapeutics

Job title: Chief Scientific Officer

Seminars:

PeptiCRAd – A Novel Oncolytic Virus Based Peptide Vaccine Delivery Platform 4:30 pm

Combining PeptiCRAd technology with oncolytic adenovirus and peptide vaccine proving a flexible therapeutic vaccine platform focused on generating cytotoxic T-cell responses against multiple tumor antigens simultaneously Local intratumoral treatment with PeptiCRAd creates systemic anti-tumor T-cell immunity and is synergistic with checkpoint blockade therapy First-in-human clinical trial in combination with PeptiCRAd-1 and pembrolizumab starting H2/2022Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.